Professor David Newby is British Heart Foundation Duke of Edinburgh Chair of Cardiology at the University of Edinburgh, Director of Edinburgh Imaging facilities, and a Consultant Interventional Cardiologist at Royal Infirmary of Edinburgh. He has major interests in advanced imaging and clinical trials of cardiovascular disease and has been involved in several multicentre trials. He is Chief Investigator for the SCOT-HEART and SCOT-HEART 2 trials.

Professor Michelle Williams is a Professor of Cardiovascular Imaging at the University of Edinburgh and Honorary Consultant Radiologist at NHS Lothian. She is Associate Director of the British Heart Foundation Data Science Centre and the Imaging theme lead. Her research centers around multi-modality non-invasive imaging of the heart and blood vessels, including using machine learning and other advanced analytic techniques. She is president of the British Society of Cardiovascular Imaging, member of the executive community of the European Society of Cardiovascular Radiology, member of the Board of Directors of the SCCT, and chair of the SCCT education committee.

Abdul Ihdayhid is a Structural Interventional Cardiologist and Cardiac CT Specialist at Fiona Stanley Hospital, as well as the Director of Cardiology Research. Abdul undertook interventional fellowships at MonashHeart, Monash Medical Centre and a post-doctoral fellowship at the St Paul’s Hospital in Canada, in advanced cardiac imaging and structural heart intervention. He completed his PhD in intracoronary physiology and cardiac CT at Monash University.

Professor John Greenwood is the Director of the Baker Heart and Diabetes Institute, Melbourne, Australia and Adjunct/Visiting Professor at Melbourne University, Monash University, and also the University of Leeds, UK. As a consultant cardiologist for 20 years, he has specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging. Professor Greenwood underwent his clinical and academic training in Leeds, UK, and in addition underwent specialist training in coronary intervention in Toulouse, France and Cardiovascular Magnetic Resonance (CMR) imaging at the Royal Brompton Hospital, London. His main focus of research has been the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of pulse sequence development and validation through large scale clinical trials. In terms of therapeutics, he has collaborated on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction or stable complex coronary artery disease. In particular, early phase clinical trials of drugs and devices to reduce infarct size in the setting of acute myocardial infarction. He is the immediate Past-President of the British Cardiovascular Society (BCS; 2021-2024) and a member of Council of The Royal College of Physicians, London. He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2008, and became BSCMR President (2018-2020). He is past-Chair of the SCMR clinical trials committee (2015-2017) and member of the SCMR scientific programme committee (2016-2019). He was the SCMR representative on the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. He was a winner of the SCMR Gold Medal in 2023 and Associate Editor of JCMR (2017-2023). He is a member of the ESC Cardio-policy group (2022-2024), ESC Advocacy Committee (2021-current) and a past member of the Assembly of International Governors of the ACC (2021-2024). He has supervised/co-supervised to completion ~30 MD/PhD students and has ~400 peer-reviewed publications, including many in NEJM, Lancet, JAMA, Circulation, JACC and EHJ.

Professor Andrew Taylor is a full-time a consultant cardiologist with the Department of Cardiovascular Medicine, Alfred Hospital, and a NHMRC Leadership Investigator at Monash University. He works as a clinician in the Heart Failure and Transplant Unit, and has a strong research interest in advanced cardiac imaging techniques and heart failure. In 2002, Prof. Taylor carried out a year of post doctoral research in Berlin, Germany, in cardiovascular magnetic resonance (CMR) imaging, and he heads both the CMR and cardiac CT angiography services at the Alfred Hospital. Prof. Taylor has been an invited speaker in cardiac imaging at numerous local and international cardiology meetings, and he has published over 150 peer-reviewed journal articles, including in the highest ranking cardiology journals Circulation and JACC.

Professor Girish Dwivedi, MD, DM, MRCP (UK), PhD (UK), FESC, FASE, FSCCT, FCSANZ, is the inaugural Wesfarmers Chair in Cardiology at the Harry Perkins Institute of Medical Research, University of Western Australia (UWA), and Consultant Cardiologist at Fiona Stanley Hospital, Murdoch, Perth. He leads the "Advanced Clinical and Translational Cardiovascular Imaging" group at the Harry Perkins Institute of Medical Research (University of Western Australia) and also holds the position of Joint Head of the Cardiovascular Disease and Diabetes Program at Perkins, as well as serving as the Director of the Cardiometabolic Clinic at the Centre for Cardiometabolic Health and Research, Fiona Stanley Hospital. He has >250 manuscripts accepted or published. Several of his original research manuscripts have been published in top-tier journals such as Annals of Internal Medicine, JACC, Circulation, JACC-Imaging, and Circulation Heart Failure. He has written chapters in a highly prestigious book in Cardiology (Principles and Practice of Clinical Cardiovascular Genetics published by Oxford University Press). His group has conducted pioneering work examining the association of inflammation and atherosclerosis. He has utilized a trans-disciplinary approach that involves translational medicine and novel cardiovascular imaging methods in assessing subclinical atherosclerosis in distinct inflammatory clinical phenotypes. This body of work has received many grants and generated several publications in high-impact journals such as Annals of Internal Medicine, Chest, Journal of Nuclear Cardiology, and AJP-Heart and Circulatory Physiology. After arriving in Perth, he has collaborated closely with the Computer Science colleagues at UWA. Dr. Dwivedi started working with a MedTech start-up company based in Perth (Artrya Ltd) soon after its inception as the Chief Medical Officer and as Chief Scientific Officer (since 2021). Their joint research program is focused on the development of artificial intelligence algorithms to automate advanced and novel cardiac CT biomarker assessment towards heart disease events. Dr. Dwivedi contributed to the development of the intellectual property, resulting in a TGA approved product.

A/Prof Rebecca Kozor is a physician-researcher with roles as a consultant cardiologist at Royal North Shore Hospital Sydney and as Associate Professor at the University of Sydney. She has specialist expertise in cardiac imaging, particularly cardiovascular magnetic resonance imaging.

Joseph Selvanayagam is an internationally recognised authority in cardiac imaging. He holds the Chair of Cardiovascular Medicine at Flinders University and is a Senior Clinical Cardiologist at Flinders Medical Centre, where he is the Director of Non-Invasive Cardiac Imaging. As the Director of Cardiac Imaging Research Group (CIRG), SA Health and Medical Research Institute (SAHMRI), he leads a group with an international reputation in randomised clinical trials, cardiomyopathy and cardiac imaging research. He graduated with first class Honours from the University of Adelaide in 1995, obtained his FRACP (Cardiology) in 2002 and his PhD from Oxford University (DPhil) in 2005. For his doctoral and post-doctoral work he received the Wellcome Trust (UK) Cardiovascular Research Fellowship, UK Overseas Research Students Awards Scheme and the Intermediate Research Fellowship award from the British Heart Foundation. In addition during this time, he received several national and international awards, including a merit award from Oxford University, and the Samuel Levine Finalist Award of the American Heart Association. Over the course of his research career he has attracted more than 28million AUD in grant funding. Prof Selvanayagam has published > 450 peer-reviewed manuscripts/abstracts/book chapters with an h-index of 48 and >16000 citations [source: Scopus].